Optimi Health completes psilocybin batch for trial and Australia supply
Tweet Send to a Friend
Optimi Health Corp. (NASDAQ: OPTH, CSE: OPTI) announced the completion and quality release of a production batch of 5mg naturally ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


